Approval · Notice of Compliance 15043 · 2013
TESTIM 1%: Notice of Compliance 15043
Issued December 3, 2013
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 15043
- Date
- December 3, 2013
- Company
- Auxilium Pharmaceuticals Inc
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- To implement changes to the drug product release and shelf life specifications for impurities
- Therapeutic class
- Tetosterone
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| TESTIM 1% | Not yet assigned | — |
Medicinal ingredients
- TESTOSTERONE 1 PER